With higher levels of IFN-β, IL-17A and IL-1β and increased numbers of CD4+ T cells in the lymph nodes and spleen, ZR8 peptide is the best vaccine candidate against subcutaneous sporotrichosis. Here, IL17A is linked to sporotrichosis.